Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 299

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Ben‐Shachar, D., Eshel, G., Finberg, J. P. M., Youdim, M. B. H.·1991·Journal of Neurochemistry

Abstract

Abstract: A selective increase in content of iron in the pars compacta of the substantia nigra has been implicated in the biochemical pathology of Parkinson's disease. Iron is thought to induce oxidative stress by liberation of oxygen free radicals from H 2 O 2. Because 6‐hydroxydopamine (6‐OHDA) is thought to induce nigrostriatal dopaminergic neuronal lesions via metal‐catalyzed free radical formation, the effect of the iron chelator desferrioxamine was investigated on 6‐OHDA‐induced dopaminergic neuron degeneration in the rat. Intracerebroventricular injection of 6‐OHDA (250 μg) caused a 88, 79, and 70% reduction in striatal tissue content of dopamine (DA), 3,4‐dihydroxyphenylacetic acid, and homovanillic acid (HVA), respectively, and a 2.5‐fold increase in DA release as indicated by the HVA/DA ratio. Prior injection of desferrioxamine (130 ng i.c.v.) resulted in a significant protection (<60%) against the 6‐OHDA‐induced reduction in striatal DA content and a normalization of DA release. Dopaminergic‐reiated behavioral responses, such as spontaneous movements in a novel environment and rearing, were significantly impaired in the 6‐OHDA‐treated group. By contrast, the desferrioxamine‐pretreated rats exhibited almost normal behavioral responses. The ability of iron chelators to retard dopaminergic neurodegeneration in the substantia nigra may indicate a new therapeutic strategy in the treatment of Parkinson's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.1991.tb11444.x

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 299

Metadata

Authors
Ben‐Shachar, D., Eshel, G., Finberg, J. P. M., & Youdim, M. B. H.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
1991-04
Volume
56
Issue
4
Pages
1441-1444
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1989277130
Cited by
299
References
29
FWCI
14.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons. https://app.cochat.ai/papers/10.1111/j.1471-4159.1991.tb11444.x
The paper
Ben‐Shachar, D., Eshel, G., Finberg, J. P. M., & Youdim, M. B. H. (1991). The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1991.tb11444.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.